Essential oil composition, antioxidant, antidiabetic and antihypertensive properties of two Afromomum species

Journal of Oleo Science

Volumn 66, Issue 1, 2017, Pages 51-63

  Adefegha, Stephen Adeniyi ^a   Olasehinde, Tosin Abiola ^b   Oboh, Ganiyu ^a  

^a FEDERAL UNIVERSITY OF TECHNOLOGY   (Nigeria)

^b Federal Institute of Industrial Research   (Nigeria)

Author keywords

Afromomum danielli; Afromomum melegueta; Antioxidants; Essential oil; Hypertension; Type 2 diabetes

Indexed keywords

AMYLASES; ANTIOXIDANTS; DRUG PRODUCTS; FREE RADICALS; GAS CHROMATOGRAPHY; GAS OILS; LIPIDS; MASS SPECTROMETRY; OXIDATION; RATS;

AFROMOMUM DANIELLI; AFROMOMUM MELEGUETA; ANGIOTENSIN I-CONVERTING ENZYME; ANTIHYPERTENSIVE PROPERTIES; ESSENTIAL OIL COMPOSITION; GAS CHROMATOGRAPHY-MASS SPECTROMETRIES (GC-MS); HYPERTENSION; TYPE-2 DIABETES;

ESSENTIAL OILS;

ALPHA GLUCOSIDASE; AMYLASE; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; DIPEPTIDYL CARBOXYPEPTIDASE; ENZYME INHIBITOR; ESSENTIAL OIL;

ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DIABETES MELLITUS, TYPE 2; DOSE RESPONSE; DRUG EFFECTS; HYPERTENSION; ISOLATION AND PURIFICATION; LIPID PEROXIDATION; METABOLISM; RAT; STRUCTURE ACTIVITY RELATION; ZINGIBERACEAE;

ALPHA-AMYLASES; ALPHA-GLUCOSIDASES; ANIMALS; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HYPERTENSION; HYPOGLYCEMIC AGENTS; LIPID PEROXIDATION; OILS, VOLATILE; PEPTIDYL-DIPEPTIDASE A; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; ZINGIBERACEAE;

EID: 85008385734     PISSN: 13458957     EISSN: 13473352     Source Type: Journal    
DOI: 10.5650/jos.ess16029     Document Type: Article

References (44)

1. Ceriello, A. New insights on oxidative stress and diabetic complications may lead to a “causal” antioxidant therapy. Diabetes Care 26, 1589-1596 (2003).
2. Jin, L.; Xue, H.Y.; Jin, L.J.; Li, S.Y.; Xu, Y.P. Antioxidant and pancreasprotective effect of aucubin on rats with streptozotocin-induced diabetes. Eur. J. Pharmacol. 582, 162-167 (2008).
3. Robertson, R.P.; Harmon, J.; Oanh, P.; Tran, T.; Poitout, V. β-Cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 53, S119-S124 (2004).
4. Miyazaki, Y.; Kawano, H.; Yoshida, T.; Miyamoto, S.; Hokamaki, J.; Nagayoshi, Y.; Yamabe, H.; Nakamura, H.; Yodoi, J.; Ogawa, H. Pancreatic B-cell function is altered by oxidative stress induced by acute hyperglycaemia. Diabet. Med. 24, 154-160 (2007).
5. Robertson, R.P. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J. Bio. Chem. 279, 42351-42354 (2004).
6. Ceriello, A. Possible role of oxidative stress in the pathogenesis of hypertension. Diabetes Care 31, S181-S184 (2008).
7. Kumar, K.V.; Das, U.N. Are free radicals involved in the pathobiology of human essential hypertension? Free Radic. Res. Commun. 19, 59-66 (1993).
8. Rajagopalan, S.; Kurz, S.; Munzel, T.; Tarpey, M.; Freeman, B.A.; Griendling, K.K.; Harrison, D.G. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/ NADPH oxidase activation: contribution to alterations of vasomotor tone. J. Clin. Invest. 97, 1916-1923 (1997).
9. Pryor, W.A.; Squadrito, G.L. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am. J. Physiol. 268, L699-L722 (1995).
10. White, C.R.; Brock, T.A.; Chang, L.Y.; Crapo, J.; Briscoe, P.; Ku, D.; Bradley, W.A.; Gianturco, S.H.; Gore, J.; Freeman, B.A. Superoxide and peroxynitrite in atherosclerosis. Proc. Natl. Acad. Sci. USA 91, 1044-1048 (1994).
11. Valko, M.; Leibfritz, D.; Moncola, J.; Mark, T. D.; Cronin, M.T.; Mazur, M.; Telser, J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39, 44-84 (2007).
12. Touyz, R.M. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44, 248-252 (2004).
13. Chaudhary, S.K.; Mukherjee, P.K.; Maity, N.; Nema, N.K.; Bhadra, S.; Saha, B.P. Ocimum sanctum L. a potential angiotensin converting enzyme (ACE) inhibitor useful in hypertension. Indian J. Natural prod. Res. 5, 83-87 (2014).
14. Adegoke, G.O.; Iwahashi, H.; Komatsu, Y.; Obuchi, K.; Iwahashi, Y. Inhibition of food spoilage yeast and aflatoxigenic mold by monoterpenes of the spice Aframomum danielli. Flavour Frag. J. 1, 147-150 (2004).
15. Thomas, D.; Thomas, J.; BromLey, W.; Mbenkum, F. Korup ethnobotany survey, final report to: The World Wide Fund for Nature. Weyside Park, Godalming, Surrey, UK. Penda House (1989).
16. Ilic, N; Schmidt, B.M.; Poulev, A.; Raskin, I. Toxicological evaluation of grains of paradise (Aframomum melegueta) [Roscoe] K. Schum. J. Ethnopharmacol. 127, 352-356 (2010).
17. Ogbole, O.O.; Ajaiyeoba, E.O. Traditional management of tuberculosis is Ogun State of Nigeria: the practice and ethnobotanical survey. Afr. J. Tradit. Complement Altern. Med. 7, 79-84 (2009).
18. Gbolade, A. Ethnobotanical study of plants used in treating hypertension in Edo State of Nigeria. J. Ethnopharmacol. 144, 1-10 (2012).
19. Lans, C.; Harper, T.; Georges, K.; Bridgewater, E. Medicinal and ethnoveterinary remedies of hunters in Trinidad. BMC Complement Altern. Med. 1, 10 (2001).
20. European Pharmacopoeia. 3rd ed. Council of Europe Press, Strasbourg, pp.121-122 (1997).
21. Singleton, V.L.; Orthofer, R.; Lamuela-Raventos, R.M. Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin–Ciocalteau ‘s reagent. Methods Enzymol. 299, 152-178 (1999).
22. Meda, A. Lamien, C.E.; Romito, M.; Millogo, J.; Nacoulma, O.G. Determination of the total phenolic, flavonoid and proline con- tents in Burkina Faso honey, as well as their radical scavenging activity. Food Chem. 91, 571-577 (2005).
23. Worthington Biochemical Corp. Worthington enzyme and related biochemicals. Freehold, NJ: Worthington Biochemical Corp(. 2001).
24. Apostolidis, E.; Kwon, Y.I.; Shetty, K. Inhibitory potential of herb, fruit, and fungal-enriched cheese against key enzymes linked to type 2 diabetes and hypertension. Inn. Food Sci. Emer. Technol. 8, 46-54 (2007).
25. Cushman, W.; Cheung, H.S. Spectrophotometric assay and properties of the Angiotensin I- converting enzyme of rabbit lung. Biochem. Pharmacol. 20, 1637-1648 (1971).
26. Mercocci, L.; Marguire, J.J.; Droy-Lefaiz, M.T. Parker, L. The nitric oxide scavenging properties of Ginkgo biloba extract EGB 761. Biochem. Biophys. Res. Comm. 201, 748-755 (1994).
27. Halliwell, B.; Gutteridge, J.M.C. Formation of a thiobarbituric-acid- reactivesubstance from deoxyribose in the presence of iron salts: The role of superoxide and hydroxyl radicals. FEBS Lett. 128, 347-352 (1981).
28. +- dependent lipid peroxidation. Free Rad. Biol. Med. 3, 379-387 (1987).
29. Puntel, R.L.; Nogueira, C.W.; Rocha, J.B.T. Krebs cycle intermediates modulate thiobarbituric reactive species (TBARS)production in rat brain in vitro. Neurochem. Res. 30, 225-235 (2005).
30. Belle, N.A.V.; Dalmolin, G.D.; Fonini, G.; Rubim, M.A.; Rocha, J.B.T. Polyamines reduces lipid peroxidation induced by different pro-oxidant agents. Brain Res. 1008, 245-251 (2004).
31. Ohkawa, H.; Ohishi, N.; Yagi, K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95, 351-358 (1979).
32. Reshma, M.V.; Namitha, L.K.; Sundaresan, A.; Kiran, C.R. Total phenol content, antioxidant activities and α-glucosidase inhibition of sesame cake extracts. J. Food Biochem. 22, 1-9 (2012).
33. Shinde, J.; Taldone, T.; Barletta, M.; Kunaparaju, N.; Hu, V.; Kumar, S.; Placido, J.; Zito, S.W. Alpha-glucosidase inhibitory activity of Syzygium cumini (Linn.) Skeels seed kernelin vitroand in Goto-Kakizaki (GK) rats. Carbohydr. Res. 343, 1278-128 (2008).
34. Shobana, S.; Sreerama, Y.N.; Malleshi, N.G. Composition and enzyme inhibitory properties of finger millet (Eleusine coracana L.) seed coat phenolics: Mode of inhibition of a-glucosidase and pancreatic amylase. Food Chem. 115, 1268-1273 (2009).
35. Krentz, A.J.; Bailey, C.J. Oral antidiabetic agents. Drugs 65, 385-111 (2005).
36. Basak, S.F.; Candan, F. Chemical composition and in vitro antioxidant and antidiabetic activities of Eucalyptus camaldulensis Dehnh. essential oil. J. Iran Chem. Soc. 7, 216-226 (2010).
37. Kwon, Y.I.; Vattem, D.A.; Shetty, K. Evaluation of clonal herbs of Lamiaceae species for management of diabetes and hypertension. Asia Pac. J. Clin. Nutr. 15, 107-118 (2006).
38. Mansour, M.B.; Balti, R.; Rabaoui, L.; Bougate, A.; Guerfel, M. Chemical composition, angiotensin -I-converting enzyme (ACE) inhibitory, antioxidant and antimicrobial activities of the essential oil from south Tunisian Ajuga pseudoiva Rob. Laminaceae. Process Biochem. doi.org/10.1016/j.procbio (2013).
39. Maritim, A.C., Sanders, R.A.; Watkins, J.B. Diabetes, oxidative stress and antioxidants: a review. J. Biochem. Mol. Toxicol. 17, 24-38 (2003).
40. Zhou, X.J.; Vaziri, N.D.; Wang, X.Q.; Silva, F.G. Laszik, Z. Nitric oxide synthase expression in hypertension induced by inhibition of glutathione synthase. J. Pharm. Exp. Ther. 300, 762-767 (2002).
41. Boligon, A.A.; Schwanz, T.G.; Piana, M.; Bandeira, R.V.; Frohlich, J.K.; de Brum, T.F.; Zadra, M.; Athayde, M.L. Chemical composition and antioxidant activity of the essential oil of Tabernaemontana catharinensisA. DC. leaves. Nat. Prod. Res. 27, 68-71 (2013).
42. Oboh, G; Olasehinde, T.A.; Ademosun, A.O. Essential oil from lemon peels inhibit key enzymes linked to neurodegenerative conditions and pro-oxidant induced lipid peroxidation. J. Oleo Sci. 63, 373-381 (2014).
43. Oboh, G.; Rocha, J.B.T. Antioxidant in foods: a new challenge for food processors: leading edge antioxidants research. Nova Science Publishers Inc., New York US, pp. 35-64 (2007).
44. Oboh, G.; Akinbola, I.A.; Ademosun, A.O.; Sanni, D.M.; Odubanjo, O.V.; Olasehinde, T.A., Oyeleye, S.I. Essential Oil from Clove Bud (Eugenia aromatica Kuntze) Inhibit Key Enzymes Relevant to the Management of Type-2 Diabetes and Some Prooxidant Induced Lipid Peroxidation in Rats Pancreas in vitro. J. Oleo Sci. 64, 775-782 (2015).